NEKTAR THERAPEUTICS (NKTR)
US6402681083 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -276.06M | -368.20M | -523.80M | -444.40M | -440.70M | |||
| Depreciation Amortization | 7.82M | 13.00M | 14.10M | 14.20M | 13.20M | |||
| Income Taxes - Deferred | -140.00K | 2.70M | N/A | N/A | N/A | |||
| Change In Working Capital | -19.80M | 500.00K | -23.10M | 16.70M | 21.70M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 9.70M | 19.20M | |||
| Taxes Paid | 2.66M | 300.00K | 300.00K | 500.00K | 600.00K | |||
| Other non cash items | 95.58M | 48.00M | 120.10M | 100.30M | 77.10M | |||
| OPERATING CASH FLOW | -192.61M | -304.00M | -412.70M | -313.30M | -328.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -865.00K | -5.70M | -15.00M | -7.30M | -26.30M | |||
| Other Investing Activity | 140.43M | 371.50M | 217.80M | 503.50M | 233.20M | |||
| INVESTING CASH FLOW | 139.56M | 365.80M | 202.80M | 496.20M | 206.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | -250.00M | 0.00 | |||
| Stock Issued/Repurchased | 30.00K | 800.00K | 33.20M | 23.40M | 23.40M | |||
| Other Financing Activity | 0.00 | 800.00K | 3.00M | 146.30M | N/A | |||
| FINANCING CASH FLOW | 30.00K | 1.50M | 36.20M | -80.40M | 23.40M | |||
| Exchange Rate Effect | 62.00K | -300.00K | -100.00K | 0.00 | -100.00K | |||
| CHANGE IN CASH | -52.95M | 63.00M | -173.80M | 102.50M | -98.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -192.61M | -304.00M | -412.70M | -313.30M | -328.70M | |||
| Capital Expenditure | -865.00K | -5.70M | -15.00M | -7.30M | -26.30M | |||
| FREE CASH FLOW | -193.47M | -309.70M | -427.70M | -320.60M | -355.00M | |||
All data in USD